ClassID:

20328

A61K31/4164 - page 4 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole 1,3-Diazoles

Recent Application in this class:
#901
20160310466
2016-10-27

COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA, MILD HYPEROPIA, AND IRREGULAR ASTIGMATISM

#902
20160310440
2016-10-27

Hypromellose-graft-chitosan and methods thereof for sustained drug delivery

#903
20160303145
2016-10-20

Small molecules that promote skin regeneration

#904
20160297754
2016-10-13

N-substituted benzamides and methods of use thereof

#905
20160289212
2016-10-06

Hepatitis B antiviral agents

#906
20160287704
2016-10-06

Topical Pharmaceutical Cosmetic and Disinfectant Compositions Comprising Phosphatidylcholine

#907
20160287616
2016-10-06

Anti-fatigue composition

#908
20160287566
2016-10-06

Anti-demodectic active agents and topical compositions for the treatment of demodicosis in humans and animals

#909
20160279053
2016-09-29

Composition and method for treatment of ulcers

#910
20160271110
2016-09-22

Oxymetazoline for the treatment of ano-rectal disorders

#911
20160266079
2016-09-15

Selenium-containing compound

#912
20160263229
2016-09-15

Platform drug delivery system utilizing crystal engineering and theanine dissolution

#913
20160263224
2016-09-15

Platform drug delivery system utilizing crystal engineering and theanine dissolution

#914
20160263138
2016-09-15

Platform drug delivery system utilizing crystal engineering and theanine dissolution

#915
20160257655
2016-09-08

Synthesis of novel inhibitors of isoprenoid biosynthesis (ISPF)

#916
20160256476
2016-09-08

NOVEL PARASITE THERAPY

#917
20160256439
2016-09-08

Prevention and treatment of non-alcoholic fatty liver disease

#918
20160256438
2016-09-08

Catalytic scavengers of organophosphates to potentiate butyrylcholinesterase (hBChE) as a catalytic bioscavenger and methods for making and using them

#919
20160250253
2016-09-01

STRONTIUM-CONTAINING COMPLEXES FOR TREATING GASTROESOPHAGEAL REFLUX AND BARRETT'S ESOPHAGUS

#920
20160250175
2016-09-01

Combined application of isothiocyanate compound and anti-cancer medicine

#921
20160250142
2016-09-01

INHALED AEROSOLIZED IMMUNO-CHEMOTHERAPY FOR THE TREATEMENT OF MDR TB

#922
20160244813
2016-08-25

Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens

#923
20160243132
2016-08-25

Methods for inhibiting muscle atrophy

#924
20160237060
2016-08-18

3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals

#925
20160235763
2016-08-18

Use of REDD1 inhibitors to dissociate therapeutic and adverse atrophogenic effects of glucocorticoid receptor agonists

#926
20160235693
2016-08-18

Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level

#927
20160235673
2016-08-18

Delayed release pharmaceutical formulation containing porous carrier particles for colon targeting

#928
20160221956
2016-08-04

Liver X receptor (LXR) modulators

#929
20160220580
2016-08-04

Methods of increasing satellite cell proliferation with kinase inhibitors

#930
20160220565
2016-08-04

Compounds, Formulations, and Methods for Treating or Preventing Inflammatory Skin Disorders

#931
20160220536
2016-08-04

USE OF PHENYLMETHIMAZOLES, METHIMAZOLE DERIVATIVES, AND TAUTOMERIC CYCLIC THIONES FOR THE TREATMENT OF AUTOIMMUNE/INFLAMMATORY DISEASES ASSOCIATED WITH TOLL-LIKE RECEPTOR OVEREXPRESSION

#932
20160214993
2016-07-28

GLP-1 receptor modulators

#933
20160213693
2016-07-28

Treatment and/or prevention of bone metastasis

#934
20160199488
2016-07-14

Combination therapy for neoplasia treatment

#935
20160194405
2016-07-07

ANTI-TISSUE FACTOR ANTIBODIES AND COMPOSITIONS

#936
20160193431
2016-07-07

Medical delivery devices and methods for applying a barrier composition to a targeted skin surface

#937
20160193307
2016-07-07

Method and compositions for inhibiting or preventing adverse effects of oral antibiotics

#938
20160193286
2016-07-07

Treatment of rhinosinusitis with P-glycoprotein inhibitors

#939
20160193194
2016-07-07

Compositions and methods for the treatment of presbyopia

#940
20160193193
2016-07-07

Compositions and methods for the treatment of presbyopia

#941
20160185733
2016-06-30

Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

#942
20160185730
2016-06-30

Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases

#943
20160184493
2016-06-30

PARTIALLY ABSORBABLE FIBER-REINFORCED COMPOSITES FOR CONTROLLED DRUG DELIVERY

#944
20160184354
2016-06-30

ROSACEA TREATMENTS AND KITS FOR PERFORMING THEM

#945
20160184342
2016-06-30

TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN

#946
20160184269
2016-06-30

Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration

#947
20160176824
2016-06-23

1,3-Disubstituted cyclopentane derivatives

#948
20160175285
2016-06-23

Dexmedetomidine premix formulation

#949
20160166511
2016-06-16

APPETISING MEDICAMENT FOR ORAL ADMINISTRATION IN SOLID FORM

#950
20160158263
2016-06-09

Treatment of papulopustular rosacea with ivermectin

#951
20160158261
2016-06-09

Antibiotic Kit and Composition and Uses Thereof

#952
20160158204
2016-06-09

Pharmacological stimulation to facilitate and restore standing and walking functions in spinal cord motor disorders

#953
20160158199
2016-06-09

Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists

#954
20160151333
2016-06-02

Methods and compositions to prevent or treat bacterial infections

#955
20160151322
2016-06-02

METALLO-B-LACTAMASE INHIBITORS

#956
20160146839
2016-05-26

Electrified compositions for determining the risk of developing adolescent idiopathic scoliosis through the use of GI protein receptor

#957
20160144007
2016-05-26

TREATMENT OF CONDITIONS RELATED TO SHOCK

#958
20160143941
2016-05-26

NUTRACEUTICAL COMPOSITION AND METHODS FOR PREVENTING OR TREATING MULTIPLE SCLEROSIS

#959
20160143907
2016-05-26

Methods and Compositions for Treating Clostridium difficile Associated Disease

#960
20160130214
2016-05-12

1,3-diaminocyclopentane carboxamide derivatives

#961
20160129075
2016-05-12

COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASE

#962
20160128935
2016-05-12

METHOD OF TREATING AN ANIMAL

#963
20160113910
2016-04-28

Treating infections with ceftolozane/tazobactam in subjects having impaired renal function

#964
20160106767
2016-04-21

Use of PKC-iota inhibitors for the treatment of breast cancer

#965
20160106761
2016-04-21

Ophthalmologic irrigation solutions and method

#966
20160106752
2016-04-21

Use of CB1 antagonists and/or inverse agonists for the preparation of drugs that increase motor neuron excitability

#967
20160106714
2016-04-21

Aqueous-based metronidazole gel formulations

#968
20160106713
2016-04-21

Nitric oxide scavengers

#969
20160101184
2016-04-14

Surfactant-free water-free foamable compositions, breakable foams and gels and their uses

#970
20160101083
2016-04-14

Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles

#971
20160101068
2016-04-14

Anti-cancer cycloalkyl diamines

#972
20160095872
2016-04-07

Therapeutic compositions comprising imidazole and imidazolium compounds

#973
20160067264
2016-03-10

MEDICAMENT AND METHOD OF DIAGNOSIS

#974
20160067220
2016-03-10

METHODS OF TREATING PEDIATRIC PATIENTS USING DEXMEDETOMIDINE

#975
20160067219
2016-03-10

Arthroscopic Irrigation Solution and Method for Peripheral Vasoconstriction and Inhibition of Pain and Inflammation

#976
20160067218
2016-03-10

Secnidazole for use in the treatment of bacterial vaginosis

#977
20160051553
2016-02-25

Molecular and Herbal Combinations with Methotrexate for Treating Diseases and Inflammatory Ailments

#978
20160045514
2016-02-18

Compounds and methods for inducing chondrogenesis

#979
20160038562
2016-02-11

Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens

#980
20160038495
2016-02-11

Bruton's tyrosine kinase inhibitor combinations and uses thereof

#981
20160038476
2016-02-11

Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity

#982
20160038468
2016-02-11

RIFAXIMIN FOR USE IN THE TREATING OF VAGINAL INFECTIONS

#983
20160038466
2016-02-11

Pharmaceutical compositions comprising (3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl)methanol

#984
20160038465
2016-02-11

Compositions and methods for non-surgical treatment of Ptosis

#985
20160038455
2016-02-11

S1P receptors modulators and their use thereof

#986
20160030472
2016-02-04

XENON-BASED ANESTHETIC GAS COMPOSITION USABLE DURING AN ENDARTERECTOMY INVOLVING THE CLAMPING OF THE CAROTID ARTERY

#987
20160030393
2016-02-04

Compounds as opioid receptor modulators

#988
20160030392
2016-02-04

Treatment or prevention of hypotension and shock

#989
20160022676
2016-01-28

Topical medications for bruises and burns

#990
20160022606
2016-01-28

NOVEL THERAPY FOR PROSTATE CARCINOMA

#991
20160015688
2016-01-21

Compounds for treatment of cancer

#992
20160008340
2016-01-14

Pharmaceutical composition including migratory factor for guiding pluripotent stem cells to injury

#993
20160008337
2016-01-14

Compositions and methods for the treatment of presbyopia

#994
20160000777
2016-01-07

METHODS OF USING HISTAMINE RECEPTOR AGONISTS AND ANTAGONISTS

#995
20160000756
2016-01-07

IMIDAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

#996
20150376716
2015-12-31

Method for examination of carcinogenic risk

#997
20150376139
2015-12-31

Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases

#998
20150374686
2015-12-31

Methods of Treating Flushing Associated with Carcinoid Tumors and Carcinoid Syndrome

#999
20150366883
2015-12-24

Method of treating ovarian cancer using a PKC inhibitor

#1000
20150366844
2015-12-24

Composition comprising a TNFR agonist and at least one thioredoxin inhibitor for use in the treatment of carcinoma

#1001
20150361077
2015-12-17

Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

#1002
20150361037
2015-12-17

Acylguanidines for treating osteoarthritis

#1003
20150359882
2015-12-17

Methods and compositions for treating associated disease

#1004
20150359781
2015-12-17

Stabilized oxymetazoline formulations and their uses

#1005
20150352102
2015-12-10

USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF ANAPHYLAXIS

#1006
20150352059
2015-12-10

Method for the treatment or prevention of lower urinary tract symptoms

#1007
20150344505
2015-12-03

Therapeutic compositions comprising imidazole and imidazolium compounds

#1008
20150335663
2015-11-26

Pharmaceutical composition having synergistic action of direct catalase inhibitors and modulators of no metabolism or of extracellular superoxide anion production which lead to catalase destruction

#1009
20150335657
2015-11-26

Methods for Modulating Sirtuin Enzymes

#1010
20150335620
2015-11-26

OIL SUSPENSION OF METRONIDAZOLE

#1011
20150328281
2015-11-19

Enteric combination therapy

#1012
20150328165
2015-11-19

PHARMACEUTICALLY ACCEPTABLE DOSAGE FORM COMPRISING RELEASE OF MULTIPLE DRUGS FROM SINGLE ORAL DOSAGE FORM

#1013
20150328151
2015-11-19

OPHTHALMIC DRUG DELIVERY

#1014
20150320781
2015-11-12

Compositions and methods for topical diagnostic and therapeutic transport

#1015
20150315156
2015-11-05

Crystal of 5-hydroxy-1H-imidazole-4-carboxamide hydrate and pharmaceutical composition thereof

#1016
20150315126
2015-11-05

Cycloproplyamine derivatives useful as inhibitors of histone demethylases KDM1A

#1017
20150313895
2015-11-05

COMBINATION TREATMENT FOR DERMATOLOGICAL CONDITIONS

#1018
20150313880
2015-11-05

Synergistic microbicidal combinations

#1019
20150313879
2015-11-05

Synergistic microbicidal combinations

#1020
20150313854
2015-11-05

Use of TRMP8 for treating opthalmic diseases or conditions involving tearing

#1021
20150313231
2015-11-05

Synergistic microbicidal combinations

#1022
20150313230
2015-11-05

Synergistic microbicidal combinations

#1023
20150306190
2015-10-29

Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions

#1024
20150306073
2015-10-29

Thioredoxin protein inhibitors and uses thereof

#1025
20150305340
2015-10-29

Synergistic microbicidal combinations

#1026
20150297569
2015-10-22

Selenium-containing compound

#1027
20150291535
2015-10-15

Packaged product of solid preparation containing 5-hydroxy-1H-imidazole-4-carboxamide or salt thereof, or hydrate thereof

#1028
20150290339
2015-10-15

NOVEL COMPOUND WITH EFFECTS OF THROMBOLYSIS, FREE RADICAL SCAVENGING AND THROMBUS-TARGETING AS WELL AS PREPARATION METHOD AND USE THEREOF

#1029
20150290276
2015-10-15

Methods of treating muscular dystrophy

#1030
20150290173
2015-10-15

TREATMENT OF SKIN OR MUCOSAL PATHOLOGY

#1031
20150290126
2015-10-15

Compositions and methods for the improvement of distance vision and the treatment of refractive errors of the eye

#1032
20150290125
2015-10-15

Storage stable compositions and methods for the treatment of refractive errors of the eye

#1033
20150283089
2015-10-08

Bilayered calcium sulfate/calcium phosphate space-making composites with multiple drug delivery capabilities

#1034
20150272948
2015-10-01

METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS

#1035
20150266890
2015-09-24

Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B

#1036
20150266813
2015-09-24

Method for preparing formamidines

#1037
20150265643
2015-09-24

Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions

#1038
20150258116
2015-09-17

Synergistic microbicidal combinations

#1039
20150252043
2015-09-10

Hematopoietic growth factor mimetic small molecule compounds and their uses

#1040
20150250179
2015-09-10

Synergistic microbicidal combinations

#1041
20150246044
2015-09-03

Therapeutic approaches for treating Parkinson's disease

#1042
20150238544
2015-08-27

Microbiota restoration therapy (MRT), compositions and methods of manufacture

#1043
20150238498
2015-08-27

Compounds for the treatment of paramoxyvirus viral infections

#1044
20150224292
2015-08-13

Medical delivery devices and methods for applying a barrier composition to a targeted skin surface

#1045
20150224071
2015-08-13

N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF

#1046
20150216847
2015-08-06

Cyclopropanecarboxylic acid derivative

#1047
20150216170
2015-08-06

Synergistic microbicidal combinations

#1048
20150209340
2015-07-30

Compounds for the treatment of associated disease

#1049
20150202238
2015-07-23

COMPOSITIONS AND METHOD FOR TREATMENT AND PROPHYLAXIS OF INFLAMMATORY BOWEL DISEASE

#1050
20150202185
2015-07-23

COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS

#1051
20150196536
2015-07-16

METHODS AND COMPOSITIONS FOR INCREASING SOLUBILITY OF AZOLE DRUG COMPOUNDS THAT ARE POORLY SOLUBLE IN WATER

#1052
20150191435
2015-07-09

Dual-acting imidazole antihypertensive agents

#1053
20150190409
2015-07-09

Topical tetracycline compositions

#1054
20150175622
2015-06-25

3-O-heteroaryl-ingenol

#1055
20150175582
2015-06-25

Synthesis of novel inhibitors of isoprenoid biosynthesis

#1056
20150174145
2015-06-25

Pharmaceutical compounds with the structure of ionic salts with antibiotic and anticancer action

#1057
20150174103
2015-06-25

Urea compounds and their use as enzyme inhibitors

#1058
20150166571
2015-06-18

Substituted quinolines as PDE-10 inhibitors

#1059
20150157652
2015-06-11

Veliparib in combination with carboplatin for the treatment of triple negative breast cancer

#1060
20150157648
2015-06-11

NUTRITIONAL APPROACH TO IMPROVING ATHLETIC PERFORMANCE AND REDUCING INJURY WITH L-ERGOTHIONEINE AND/OR VITAMIN D2

#1061
20150157612
2015-06-11

Methods of treating hepatic encephalopathy

#1062
20150150849
2015-06-04

CANCER TARGETING USING CARBONIC ANHYDRASE ISOFORM IX INHIBITORS

#1063
20150148899
2015-05-28

Sodium channel blocker delivery system with scleral lens

#1064
20150148393
2015-05-28

COSMETIC AND/OR PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN INFLAMMATION AND RELATED SYNDROMES

#1065
20150141357
2015-05-21

Shikimate pathway inhibitors and the use thereof

#1066
20150133518
2015-05-14

Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

#1067
20150125490
2015-05-07

Compositions and methods for lung regeneration

#1068
20150110838
2015-04-23

Therapeutic combinations for treating Johne's disease

#1069
20150094375
2015-04-02

Methods of colchicine administration

#1070
20150094318
2015-04-02

Methods of colchicine administration

#1071
20150094317
2015-04-02

Methods of colchicine administration

#1072
20150080443
2015-03-19

Formulations for the treatment of vaginal disorders

#1073
20150073053
2015-03-12

Treatment of drug resistant cancer

#1074
20150072968
2015-03-12

Treating Infections with Ceftolozane/Tazobactam in Subjects Having Impaired Renal Function

#1075
20150065543
2015-03-05

Dual-acting antihypertensive agents

#1076
20150065511
2015-03-05

Compositions and methods for the treatment of presbyopia

#1077
20150057359
2015-02-26

Methods of colchicine administration

#1078
20150057324
2015-02-26

Tablet containing 5-hydroxy-1H-imidazole-4-carboxamide

#1079
20150056267
2015-02-26

Angiogenesis inhibitors

#1080
20150051408
2015-02-19

Packaged product of solid preparation containing 5-hydroxy-1H-imidazole-4-carboxamide or salt thereof, or hydrate thereof

#1081
20150044193
2015-02-12

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED a-SYNUCLEIN FUNCTION

#1082
20150044173
2015-02-12

Microbiota restoration therapy (MRT), compositions and methods of manufacture

#1083
20150038480
2015-02-05

Compounds that modulate autoimmunity and methods of using the same

#1084
20150024032
2015-01-22

Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia

#1085
20150023955
2015-01-22

Treatment and diagnosis of melanoma

#1086
20150018391
2015-01-15

Animal treatments

#1087
20150018337
2015-01-15

N-(2-(hetaryl)aryl)arylsulfonamides and N-(2-(hetaryl)hetaryl)arylsulfonamides

#1088
20150018293
2015-01-15

Animal treatments

#1089
20150011601
2015-01-08

Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof

#1090
20150011491
2015-01-08

Treatment of papulopustular rosacea with ivermectin

#1091
20150011490
2015-01-08

Treatment of papulopustular rosacea with ivermectin

#1092
20150011489
2015-01-08

Treatment of inflammatory lesions of rosacea with ivermectin

#1093
20150005252
2015-01-01

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

#1094
20140378530
2014-12-25

Retinaldehyde mimetics and inhibitors of retinaldehyde dehydrogenase I in the treatment of disorders

#1095
20140378466
2014-12-25

DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK

#1096
20140377235
2014-12-25

METHODS FOR USING SYNTHETIC TRITERPENOIDS IN THE TREATMENT OF BONE OR CARTILAGE DISEASES OR CONDITIONS

#1097
20140371423
2014-12-18

Method for purification of Micafungin

#1098
20140371164
2014-12-18

Synergistic combination comprising avermectins and a NSAID for tumor inhibition

#1099
20140364373
2014-12-11

Methods for treating gastrointestinal disorders associated with Parkinson's disease, autism, diabetic gastroparesis

#1100
20140363509
2014-12-11

COMPOSITIONS FOR THE TREATMENT OF MUCOUS MEMBRANE DISEASES

#1101
20140363479
2014-12-11

Compositions and methods for treating extracellular parasitic infections

#1102
20140357587
2014-12-04

Use of Glutaryl Histamine for the Treatment of Respiratory Tract Diseases

#1103
20140350063
2014-11-27

Biotherapeutics for the treatment of infectious diseases

#1104
20140350056
2014-11-27

TRPV1 antagonists including dihydroxy substituent and uses thereof

#1105
20140348827
2014-11-27

Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof

#1106
20140343067
2014-11-20

Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors

#1107
20140343009
2014-11-20

METHODS FOR TREATING METHYLMALONIC ACIDEMIA

#1108
20140328809
2014-11-06

METHODS OF INDUCING CHONDROGENESIS IN MESENCHYMAL STEM CELLS USING SYNTHETIC TRITERPENOIDS

#1109
20140323483
2014-10-30

Type III secretion inhibitors, analogs and uses thereof

#1110
20140323423
2014-10-30

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

#1111
20140322317
2014-10-30

CONTROLLED RELEASE COMPOSITIONS

#1112
20140303222
2014-10-09

Dual-acting imidazole antihypertensive agents

#1113
20140303220
2014-10-09

Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof

#1114
20140294855
2014-10-02

Methods of increasing satellite cell proliferation

#1115
20140288136
2014-09-25

METHODS AND USES OF CYTOCHROME P450 INHIBITORS

#1116
20140286876
2014-09-25

Veterinary active agent application

#1117
20140275568
2014-09-18

Crystal of 5-hydroxy-1H-imidazole-4-carboxamide 3/4 hydrate, method for producing the same and crystal of 5-hydroxy-1H-imidazole-4-carboxamide hydrate

#1118
20140274962
2014-09-18

Methods of inhibiting presbyopia

#1119
20140271955
2014-09-18

Compounds and methods for inducing chondrogenesis

#1120
20140271923
2014-09-18

Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions

#1121
20140271921
2014-09-18

Pharmaceutical composition

#1122
20140271561
2014-09-18

Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens

#1123
20140256661
2014-09-11

PHARMACEUTICAL COMPOSITIONS FOR RECTAL ADMINISTRATION

#1124
20140249181
2014-09-04

Tropolone compounds for treating or preventing retroviral infection

#1125
20140248376
2014-09-04

Compositions for treatment of skin and ear infections

#1126
20140243340
2014-08-28

CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF

#1127
20140241998
2014-08-28

Foamable carriers

#1128
20140235599
2014-08-21

Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders

#1129
20140235597
2014-08-21

Ophthalmologic irrigation solutions and method

#1130
20140235590
2014-08-21

Pharmaceutical compounds for use in the therapy of infection

#1131
20140235562
2014-08-21

Compounds and methods of treating ocular disorders

#1132
20140228333
2014-08-14

Methods for lowering blood glucose

#1133
20140227208
2014-08-14

COSMETIC COMPOSITIONS CONTAINING SUBSTITUTED AZOLE AND METHODS FOR ALLEVIATING MECHANICALLY-INDUCED SKIN INFLAMMATION

#1134
20140227207
2014-08-14

Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin

#1135
20140227206
2014-08-14

Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin

#1136
20140221922
2014-08-07

Absorbable crystalline polyether-ester-urethane-based bioactive luminal liner compositions

#1137
20140221447
2014-08-07

Formulation for preventing or reducing bleeding at a surgical site

#1138
20140221375
2014-08-07

Method for treating proliferative disorders associated with mutations in c-Met

#1139
20140221330
2014-08-07

NDM inhibitor

#1140
20140221326
2014-08-07

Ophthalmologic irrigation solutions and method

#1141
20140220152
2014-08-07

Compositions and Methods for Detecting, Treating, or Preventing Reductive Stress

#1142
20140219966
2014-08-07

Fecal lactoferrin as a biomarker for determining disease severity and for treating infection in patients with disease

#1143
20140219965
2014-08-07

Controlling appetite, promoting weight loss, reducing body fat, and/or improving glucose tolerance

#1144
20140213624
2014-07-31

Method for treating and curing leishmaniosis using fexinidazole

#1145
20140212362
2014-07-31

Composition and method for treatment of symptoms associated with various skin conditions

#1146
20140206735
2014-07-24

HIGH DOSAGE TOPICAL METRONIDAZOLE AQUEOUS-BASED GEL FORMULATIONS AND THEIR USE TO TREAT ROSACEA

#1147
20140206690
2014-07-24

Compounds for use as therapeutic agents affecting p53 expression and/or activity

#1148
20140206636
2014-07-24

METHODS OF DIAGNOSING AND TREATING SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) AND SIBO-RELATED CONDITIONS

#1149
20140205662
2014-07-24

SYSTEM AND METHOD FOR DIFFERENTIALLY TIMED LOCAL DELIVERY OF A COMBINATION PHARMACEUTICAL PREPARATION FOR ORAL THERAPY

#1150
20140200211
2014-07-17

Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism

#1151
20140186266
2014-07-03

Conjugates of nitroimidazoles and their use as chemotherapeutic agents

#1152
20140179749
2014-06-26

FORMULATIONS OF ENZALUTAMIDE

#1153
20140178463
2014-06-26

Compositions for treating CMT and related disorders

#1154
20140171444
2014-06-19

Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof

#1155
20140162955
2014-06-12

Antagonizing Heparin With Salicylamide Compounds And Histamine Blocking Agents

#1156
20140155446
2014-06-05

Dexmedetomidine premix formulation

#1157
20140155433
2014-06-05

Biaryl derivatives as nAChR modulators

#1158
20140154338
2014-06-05

Skin cream

#1159
20140154317
2014-06-05

Pharmaceutical Composition for Treatment of Helicobacter Pylori Associated Diseases

#1160
20140148486
2014-05-29

Sodium channel blocker delivery system with scleral lens

#1161
20140135349
2014-05-15

Aqueous compositions

#1162
20140134246
2014-05-15

RAPID DISSOLVE TABLET COMPOSITIONS FOR VAGINAL ADMINISTRATION

#1163
20140134119
2014-05-15

Rosacea treatments using polymetal complexes

#1164
20140128336
2014-05-08

MEDICAL PRODUCTS FOR USE IN CONDITIONS RELATED TO MICROBIAL INFECTIONS IN THE UPPER AERODIGESTIVE TRACT

#1165
20140121257
2014-05-01

Alpha-1-adrenergic receptor agonist therapy

#1166
20140121156
2014-05-01

NUTRITIONAL APPROACH TO THE CONTROL OF ANEMIA, DIABETES AND OTHER DISEASES OR CONDITIONS AND PREVENTION OF ASSOCIATED COMORBID STATES WITH THE USE OF ERGOTHIONEINE

#1167
20140113947
2014-04-24

PHARMACEUTICAL CREAM COMPOSITIONS OF OXYMETAZOLINE AND METHODS OF USE

#1168
20140113946
2014-04-24

Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism

#1169
20140113917
2014-04-24

Pyrazole compounds as CRTH2 antagonists

#1170
20140107172
2014-04-17

Benzimidazole-imidazole derivatives

#1171
20140100257
2014-04-10

Treatment or prevention of hypotension and shock

#1172
20140100218
2014-04-10

Treatment of mild and moderate Alzheimer's disease

#1173
20140099336
2014-04-10

Methods for treating dependence

#1174
20140094444
2014-04-03

Compositions and methods for tissue engineering and cell based therapies

#1175
20140080778
2014-03-20

Use of secnidazole in treatment of dental infections

#1176
20140079791
2014-03-20

PHARMACEUTICAL PREPARATIONS CONTAINING HIGHLY VOLATILE SILICONES

#1177
20140079628
2014-03-20

Anti-tissue factor antibodies and compositions

#1178
20140066524
2014-03-06

Compositions, gels and foams with rheology modulators and uses thereof

#1179
20140066483
2014-03-06

Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists

#1180
20140066427
2014-03-06

S1P receptors modulators and their use thereof

#1181
20140057958
2014-02-27

Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases

#1182
20140051738
2014-02-20

Oxymetazoline For The Treatment Of Ano-Rectal Disorders

#1183
20140051729
2014-02-20

COMPOSITIONS AND METHODS FOR TREATING DEGENERATIVE MUSCLE CONDITIONS

#1184
20140050680
2014-02-20

Dapsone to treat rosacea

#1185
20140045779
2014-02-13

COMPOUNDS CONTAINING AN ALICYCLIE STRUCTURE AND ANTI-TUMOR APPLICATION

#1186
20140038974
2014-02-06

Compositions and Methods for Eye Whitening

#1187
20140038927
2014-02-06

Compositions for treating neurological disorders

#1188
20140037577
2014-02-06

Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles

#1189
20140031287
2014-01-30

Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide

#1190
20140031280
2014-01-30

Methods for preventing and treating post-traumatic stress disorder (PTSD)

#1191
20140030312
2014-01-30

Use of combination preparations comprising antifungal agents

#1192
20130345313
2013-12-26

Method for the treatment or prevention of lower urinary tract symptoms

#1193
20130345276
2013-12-26

Synthetic triterpenoids and methods of use in the treatment of disease

#1194
20130338208
2013-12-19

Fulvene and fulvalene analogs and their use in treating cancers

#1195
20130337047
2013-12-19

COMPOSITIONS FOR TREATING ORAL AND PERIODONTAL INFECTIONS

#1196
20130331398
2013-12-12

Modulation of ubiquitination of synaptic proteins for the treatment of neurodegenerative and psychiatric disorders

#1197
20130317042
2013-11-28

Method of treating ischemia/reperfusion injury

#1198
20130315903
2013-11-28

ARYLSULFONAMIDE DERIVATIVES FOR THE PREVENTION OR TREATMENT OF SPECIFIC OPHTHALMOLOGIC DISORDERS

#1199
20130309219
2013-11-21

Treatment and prevention of bacterial vaginosis and infections

#1200
20130309191
2013-11-21

Compounds for the treatment of -associated disease